COMPANY PROFILE // THE 014 REPORT

Akari Therapeutics Plc

AKTX (Nasdaq) · Formerly: Celsus Therapeutics Plc.; Morria Biopharmaceuticals PLC

Assembled from 2 government sources in 2.5 s

Built from public records at 2026-11-22 05:06 ET. Every figure links to its source. Flags and checks built 2026-11-21 21:52 ET. Sources

FLAGS · DISCLOSURE · SUMMARY

Missing or hidden

  • AmberNT 10-Q filed on 2026-05-18: notice that a periodic report would be late (2 such notices in 24 months).2026-05-18 · source
  • Amber8-K Item 3.01 filed: notice of delisting, of a failed continued-listing rule, or of a transfer of listing on 2025-11-26 (last 24 months).2025-11-26 · source
  • InfoRegistered business address (401 EAST JACKSON STREET, TAMPA) is shared with 15 other entities in our records (SEC registrants and IRS-registered organizations).2026-11-21 · source

✓ SEC filings✓ State registrationpossible match✗ LEI✗ SAM registration✗ IRS return✗ Website✗ Lobbying registration

No LEI, no SAM registration, no IRS return, no website, no lobbying registration on record; address shared with 15 entities.

Akari Therapeutics Plc is an SEC-registered operating company in pharmaceutical preparations, incorporated in United Kingdom, based in Tampa, FL; listed as AKTX (Nasdaq).[source] It has filed 76 documents with the SEC in the last 12 months; the latest is Form 4, filed 2026-11-19.[source] Its largest institutional holders on 13F filings are MMCAP International Inc. SPC, Cresset Asset Management, LLC, JANE STREET GROUP, LLC (as of 2026-06-30).[source] Seraphix flags 2 items from these records: 8-K Item 3.01 filed; NT 10-Q filed on 2026-05-18.[source]

0federal award recipients matched by name in USAspending
0lobbying filings name it as client
76SEC filings in the last 12 months
$1.4Mheld by its 9 largest 13F holders (as of 2026-06-30)
SEC filings by month, 24 months
2024-12: 152025-01: 62025-02: 32025-03: 172025-04: 32025-05: 82025-06: 72025-07: 62025-08: 62025-09: 22025-10: 72025-11: 62025-12: 142026-01: 52026-02: 12026-03: 82026-04: 32026-05: 62026-06: 72026-07: 72026-08: 62026-09: 02026-10: 132026-11: 52024-122026-11
Flags by level
  • red0
  • amber2
  • info1
Largest 13F holders, value as filed
  • MMCAP International Inc. SPC$1.0M
  • Cresset Asset Management, LLC$211K
  • JANE STREET GROUP, LLC$158K
  • IFP Advisors, Inc$2K
  • SBI Securities Co., Ltd.$143
  • HRT FINANCIAL LP$140
  • Caitong International Asset Management Co., Ltd$82
  • NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO$72

RECORD · WEB

Ask about this entity

Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).

PEOPLE · COUNSEL · LINKS

Leadership, advisers and links

Officers and directors (Forms 3, 4, 5)

As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.

EVERY LIST AND SOURCE · DATED

Checked and clear

26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.

List or sourceResultCheckedWhat matched
OFAC SDN (Treasury)CLEAR2026-11-20
SAM.gov exclusionsCLEAR2026-11-21
HHS-OIG LEIECLEAR2026-11-13
FARA registrants (DOJ)CLEAR2026-11-21
Regulated facility: compliance, penalties and TRI parent (EPA)CLEAR2026-11-18
Hazardous-waste handler facility (EPA RCRAInfo, sample)CLEAR2026-11-18
Consumer complaints about a company (CFPB)CLEAR2026-11-18
Corporate enforcement action (DOJ, SEC, CFTC, EPA)CLEAR2026-11-18
SEC litigation release (respondent)CLEAR2026-11-18
Federal Reserve Board enforcement action (press release, 2022 onward)CLEAR2026-11-18
Enforcement order against a savings association (OCC, OTS archive to 2011)CLEAR2026-11-18
State environmental enforcement actions (Maryland MDE, Connecticut DEEP)CLEAR2026-11-18
Firm sanctioned or debarred by the IDB Group (incl. cross-debarments by WBG, ADB, EBRD, AfDB as listed by the IDB)CLEAR2026-11-18
UK sanctions designation (FCDO UK Sanctions List)CLEAR2026-11-18
US export screening list party (Consolidated Screening List, ITA)CLEAR2026-11-18
FDA recallCLEAR2026-11-18
FDA import alert or listed firm (Red / Yellow / Green list)CLEAR2026-11-18
Consumer product recall or recalling firm (CPSC, full history)CLEAR2026-11-18
Consumer product recall (CPSC)CLEAR2026-11-18
Vehicle recall, defect investigation or manufacturer (NHTSA ODI)CLEAR2026-11-18
Vehicle recall (NHTSA)CLEAR2026-11-18
FinCEN enforcement action (civil money penalty or consent order, 1999 onward)CLEAR2026-11-18
Union representation election (NLRB)CLEAR2026-11-18
NYC summons against an organization, adjudicated at OATH (all city agencies)CLEAR2026-11-18
Data breach notice to a state Attorney GeneralCLEAR2026-11-18
Data breach notice (California Attorney General)CLEAR2026-11-18

EVERY IDENTIFIER · LINKED

ID crosswalk

IdentifierValueRecord
SEC CIK0001541157source
EIN98-1034922source
NY DOS ID4205807record
Business address (SEC)401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL, 33602source

Does not exist in the records we hold: LEI, UEI, FDIC certificate.

EACH FEEDS WATCH

Dates coming up

PEERS BY SIC CODE

Industry context

SIC 2834 (pharmaceutical preparations): 568 companies in our records share this code.

#42 of 568
federal dollars
#40 of 568
lobbying filings
#186 of 568
SEC filings in 12 months
#98 of 568
flags

Peers, each with its 014

  • PFIZER INC · 124 SEC filings in 12 months · $25.74B federal (possible match)
  • Merck & Co., Inc. · 150 SEC filings in 12 months · $13.51B federal (possible match)
  • ABBOTT LABORATORIES · 118 SEC filings in 12 months · 1 flag · $2.64B federal (possible match)
  • ASTRAZENECA PLC · 140 SEC filings in 12 months · $602.8M federal (possible match)
  • TEVA PHARMACEUTICAL INDUSTRIES LTD · 168 SEC filings in 12 months · $77.6M federal (possible match)
  • NOVARTIS AG · 34 SEC filings in 12 months · $41.9M federal (possible match)
  • Spero Therapeutics, Inc. · 41 SEC filings in 12 months · 4 flags · $39.5M federal (possible match)
  • Grifols SA · 18 SEC filings in 12 months · $22.5M federal (possible match)
  • SCYNEXIS INC · 54 SEC filings in 12 months · 3 flags · $18.5M federal (possible match)
  • Ensysce Biosciences, Inc. · 45 SEC filings in 12 months · 3 flags · $15.1M federal (possible match)
  • UNITED THERAPEUTICS Corp · 454 SEC filings in 12 months · 2 flags · $6.8M federal (possible match)
  • Zoetis Inc. · 144 SEC filings in 12 months · 1 flag · $6.7M federal (possible match)

ADDRESS · ZIP CODE

Location context

At the same address (16)

SHARED PEOPLE · SHARED ADDRESS

Network neighbours

Shared directors and officers

SEC registrants at the same address

EVERY SOURCE · NEWEST FIRST

One timeline

170 earlier entries

RENDERED FROM THIS PAGE

Relationship graph

MMCAP International Inc. SPC · holderCresset Asset Management, LLC · holderJANE STREET GROUP, LLC · holderIFP Advisors, Inc · holderSBI Securities Co., Ltd. · holderFarag Kameel D. · officer or directorGaslightwala Abizer · officer or directorBazemore Robert B · officer or directorHuh Hoyoung · officer or directorNeal James R · officer or directorARDELYX, INC. · shared boardAtlasClear Holdings, Inc. · shared boardBIOVIE INC. · shared boardNuvation Bio Inc. · shared boardAkari Therapeutics Plc

Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.

DATA MOTION // NEWEST FIRST

What changed

Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-22; the colour is also written out in words.

COUNTS FROM THIS PAGE

Relationships at a glance

9largest institutional holders (13F as filed)
0other entities in the GLEIF ownership tree (ID tier)
0awarding federal agencies
0hiring lobbying firms: possible match: matched by name only, not merged
PRICE · FILINGS · POSTS · NEWS

Market & news

Price
NASDAQ:AKTX The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
Open in
Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

Financials
Filed figures: published SEC values, each linked to its filing.
Official posts
Links to posts from the company's and agencies' verified accounts: not connected yet.
News
Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER

1. Identity

1confirmed members (SEC registrant + GLEIF ownership tree)
0legal entities (LEI) in the ownership tree
25dated filings and events

4 possible matches held apart, matched by name only, not counted above; 2 records under a former name, shown apart.

IdentifierValueHow it was resolvedSource
SEC CIK1541157id:sec-anchor: the SEC registrant record of this companySEC EDGAR
Ticker / exchangeAKTX / NasdaqSEC company record: ticker and exchange as listed on the SEC company recordSEC EDGAR
EIN981034922carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001541157SEC EDGAR / IRS
CUSIP00972G405carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001541157SEC EDGAR

former name (shown apart, not merged) (2)

AS FILED · EACH WITH ITS DATE AND FILING

2. Filed figures

Key figures (annual filing)

FigureValuePeriod or as ofSourceBasisRetrievedReport
Net income (loss) (fiscal year ended 2025-12-31)-$17,298,0002025-12-3110-K, XBRL NetIncomeLossas filed2026-11-22 10:06 UTCReport an error
Total assets (at 2025-12-31)$47,892,0002025-12-3110-K, XBRL Assetsas filed2026-11-22 10:06 UTCReport an error
Stockholders' equity (at 2025-12-31)$28,328,0002025-12-3110-K, XBRL StockholdersEquityas filed2026-11-22 10:06 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$02025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValueas filed2026-11-22 10:06 UTCReport an error

Company profile facts (SEC)

FigureValuePeriod or as ofSourceBasisRetrievedReport
SEC entity typeoperating2026-11-19SEC EDGAR company profileas filed2026-11-22 10:06 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-11-19SEC EDGAR company profileas filed2026-11-22 10:06 UTCReport an error
State of incorporationX02026-11-19SEC EDGAR company profileas filed2026-11-22 10:06 UTCReport an error
Fiscal year end (MMDD)12312026-11-19SEC EDGAR company profileas filed2026-11-22 10:06 UTCReport an error
Business address401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL, 336022026-11-19SEC EDGAR company profileas filed2026-11-22 10:06 UTCReport an error
ExchangesNasdaq2026-11-19SEC EDGAR company profileas filed2026-11-22 10:06 UTCReport an error

Other filed values

FigureValuePeriod or as ofSourceBasisRetrievedReport
Operating cash flow (fiscal year ended 2025-12-31)-$10,568,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivitiesas filed2026-11-22 10:06 UTCReport an error
Form D total offering amount (D filed 2026-06-03)$5,500,0002026-06-03Das filed2026-11-22 10:06 UTCReport an error
Form D total amount sold (D filed 2026-06-03)$1,833,3332026-06-03Das filed2026-11-22 10:06 UTCReport an error
Form D industry groupOther Health Care2026-06-03Das filed2026-11-22 10:06 UTCReport an error
Form D revenue rangeDecline to Disclose2026-06-03Das filed2026-11-22 10:06 UTCReport an error
Form D date of first sale2026-05-202026-06-03Das filed2026-11-22 10:06 UTCReport an error

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-12 · accession 0001493152-26-051372

ItemValuePeriodFormFiledAccessionRetrievedReport
Net income (loss)-$4,843,0003 months ended 2026-09-3010-Q2026-11-120001493152-26-0513722026-11-22 10:06 UTCReport an error
Interest expense$85,0003 months ended 2026-09-3010-Q2026-11-120001493152-26-0513722026-11-22 10:06 UTCReport an error
Cash and cash equivalents$5,743,000at 2026-09-3010-Q2026-11-120001493152-26-0513722026-11-22 10:06 UTCReport an error

Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.

No estimates: every value is as filed and links to the filing it came from.

Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.

NEWEST FIRST · EACH LINKS TO ITS FILING

3. Registration and filing timeline

AS FILED · LARGEST HOLDERS

10. 13F institutional holders

RankHolder (13F filer)Value heldAs ofSourceRetrievedReport
1MMCAP International Inc. SPC$1,024,5002026-06-30SEC 13F filing2026-11-22 10:06 UTCReport an error
2Cresset Asset Management, LLC$210,6472026-06-30SEC 13F filing2026-11-22 10:06 UTCReport an error
3JANE STREET GROUP, LLC$158,4182026-06-30SEC 13F filing2026-11-22 10:06 UTCReport an error
4IFP Advisors, Inc$1,8542026-06-30SEC 13F filing2026-11-22 10:06 UTCReport an error
5SBI Securities Co., Ltd.$1432026-06-30SEC 13F filing2026-11-22 10:06 UTCReport an error
6HRT FINANCIAL LP$1402026-06-30SEC 13F filing2026-11-22 10:06 UTCReport an error
7Caitong International Asset Management Co., Ltd$822026-06-30SEC 13F filing2026-11-22 10:06 UTCReport an error
8NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO$722026-06-30SEC 13F filing2026-11-22 10:06 UTCReport an error
9Truvestments Capital LLC$102026-06-30SEC 13F filing2026-11-22 10:06 UTCReport an error

13F as filed: the holder's own report of its position value at the quarter end.

POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS

13. Permits and local records

4 state and city records carry this company's exact name, from 3 sources. Possible matches only.

State licences (2)

possible match: matched by name only, not merged (2)

Possible match based on name, not a shared identifier. Compare the records.

ClinicalTrials.gov (1)

possible match: matched by name only, not merged (1)

Possible match based on name, not a shared identifier. Compare the records.

  • possible matchAKARI Therapeutics · name equals 'Akari Therapeutics' but other unrelated entities share it · sx:ctgov:h1a24d2caf1d7b78c Compare

New York corporations (1)

possible match: matched by name only, not merged (1)

Possible match based on name, not a shared identifier. Compare the records.

WHAT THIS PAGE READ

Sources

As of 2026-11-22 (record built 2026-11-22T10:06:06Z). Sources used: SEC EDGAR, SEC 13F holdings.

Not checked: FTC enforcement actions; DOJ press releases (beyond FARA and the corporate enforcement set); federal and state court records; UCC filings, liens and bankruptcy dockets; IRS automatic revocation list; state annual-report dates; company formation dates (only where a state registry record states one).

JSON · MCP · API

API and agents

The same profile as JSON: GET /company/1541157.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001541157. Every source URL used is listed in the file.

Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.